Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.

I Marks, David; Pagliuca, Antonio; C Kibbler, Christopher; Glasmacher, Axel; Heussel, Claus-Peter; Kantecki, Michal; J S Miller, Paul; Ribaud, Patricia; T Schlamm, Haran; Solano, Carlos; Cook, Gordon; Study Group, IMPROVIT

doi:10.1111/j.1365-2141.2011.08838.x

Public

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.

Shared by NobleBlocks on Nov 1, 2011 • 12:00 AM UTC

Authors:

David I Marks

Antonio Pagliuca

Christopher C Kibbler

Abstract

Antifungal prophylaxis for allogeneic haematopoietic stem-cell transplant (alloHCT) recipients should prevent invasive mould and yeast infections (IFIs) and be well tolerated. This prospective, randomized, open-label, multicentre study compared the efficacy and safety of voriconazole (234 patients) ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!